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ABSTRACT 
• • • l.l.1 
The purpose of this study was to design a bioassay 
procedure by means of which it would be possible to 
rapidly screen drugs to determina their ability to 
accelerate tooth eruption as well as their undesirable 
side effects. 
The rat maxillary 3rd molar was utilized as the 
assay parameter for measuring acceleration in tooth 
eruption. 
The method developed utilizes female rats (Charles 
River Breeding Lab), 26 days of age. Test drugs are 
injected twice; when the rats are 26 and 27 days of age; 
and the rats are sacrificed at 30 days of age. Heads 
are removed and fixed in 95% ethernol for 12 hours. 
The upper dental arches are examined under a disecting 
microscope (lOOX) and the extent of eruption scored. 
The extent of tooth eruption was determined by 
• 
comparing 3rd molars to a standardized scoring chart. 
The scor~ng chart depicts eleven progressive stages in 
the eruption of the maxillary right and left 3rd molars. 
This chart also contains a number or grade for each of 
the eleven stages (from O, for no eruption, to 10 for 
full eruption). 
In control rats there is little or no eruption of 
the 3rd molars at 30 days of age. Third molar eruption 
was enhanced more than two times with a 300 ug/kg dose 
• iv 
of T3 ; however, the treatment caused a reduction in 
the extent of weight gained. 
3' isopropyl 3-5 diiodothyronine was the most potent 
thyromimetic agent tested. Third molar eruption was 
accelerated 2½ times with a 4.7 ug/kg dose of IsoI2; a 
dose of 9.4 ug/kg IsoI2 increased molar eruption 3 
times. None of the IsoI2 treatment groups exhibited 
significant body weight changes. 
The marked sensitivity (~ =.3e) of third molar 
eruption to thyromimetic agents, suggests that our 
technique may be useful in the search for clinically 
useful compounds. In comparison to the antigoitrogenic 
assay the tooth eruption assay is simpler, more rapid, 
its reproductibility is higher; it requires much less 
test material. Should further work substantiate these 
apparent advantages of the tooth eruption assa¥, it is 
conceivable that it would at least join the antigoitrogenic 
assay as the standard means of assessing the potency of 
thyroid hormone preparations. 
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INTRODUCTION 
• 
\ 
Replacement of the primary dentition by the 
succedaneous teeth normally occurs smoothly. However, 
when this transition extends over a long period of time, 
dental management problems among others, arise. 
In situations, such as retarded tooth eruption, it 
would be ·advantageous to b~ able to stimulate the rate 
of tooth eruption. Considerable evidence suggests 
that certain agents such as thyroid hormones have this 
capacity. For example, in a group of juvenile hypo-
thyroid patients, Hirnich (1) found a retardation of 
tooth eruption. The administration of T4 lead to a 
restoration of normal eruption rates. In juvenile 
hyperthyrodism, the dental age is well advanced over 
bone age. A child 5 years of age with a dental age of 
9 has been reported. (2) 
The eruption rate of rodent incisors can be acceler-
ated by natural occuring thyroid hormones, T4 and T3, as 
well as certain synthetic thyroid analogs. (3,4,5,6,7) 
The administration of T3 and T4 in amounts sufficient 
to accelerate rodent incisor eruption als~ causes some 
undesirable side effects. The main side effects of 
thyroid hormones are interference with normal growth and 
hyper-metabolism. 
Thyroid hormones can have a growth promoting action 
(net weight gain) as well as a growth inhibiting action 
f • 
4 
(net weight loss) when given in too high a dose. (8) 
In humans, Trotter (9) has shown that prepubertal 
hyperth~_rroidism may result in retardation of linear 
growth because of a premature closure of the epiphyses. 
The hypermetabolic effect of hyperthyroidism is 
typified by an increase in 02 consumption, BMR, and 
body temperature. Increased pulse rate, cardiac output 
and pulmonary ventilation rate as -well as decreased 
cholesterol are characteristic. (10, 11) 
Because of its many and varied effects, the thyroid 
hormones (T3, T4) would not ordinarily be administered 
when on~y on~ of its many activities is desired. For 
this reason, there has been an intensive search for 
drugs which minic specific actions of thyroid hormones. 
One avenue has been to synthesize various analogs of 
thyroid hormone. Synthetic thyroid analogs differ in 
1, 
their activities. For example, L-3' methyl-diiodo-
thyronine is only three fourths as potent as T4 in 
suppressing thyrotrophin release, yet it is five times 
as active as T4 in accelerating metamorphosis in 
tadpoles. (12) 
The comparative effects of the various thyroid analogs 
are evaluated by biological assay procedures. For example, 
the "Goiter prevention" assay measures the ability of a 
drug to suppress the release of TSH. There exists a 
5 
considerable amount of information regarding the bio-
logical assay of various thyroid analogs in different 
specie~. (13, 14, 10, 12, 15, 16, 17) 
Bioassay procedures are essential for evaluating 
the relative activity of any group of drugs. Before 
a drug its released for clin .ical t -rial in humans, it 
must be subjected to a number of bioassay procedures, 
ranging from preliminary screening in small lower 
animals to more sophisticated assays in larger animals. 
The purpose of this study was to develop a pre-
liminary screen; to define and describe a bioassay 
procedure or system by means of which it would be 
possible to rapidly screen drugs to determine their 
ability to accelerate tooth eruption, as well as their 
.general undesirable side effects. 
Most studies on tooth eruption, have utilized the 
;. 
continuously erupting incisors of various rodents. This 
poses some difficulties because there is no dental 
counterpart of the rodent incisor in the human dentition. 
A more logical candidate would be the rat molar. The 
histology and physiolog~ of the rat molars appear to be 
more similiar to that of the human. The periodontal 
tissues of the rat also closely resemble that of humans. 
In addition, the form and function of the rat molar 
compare closely with that of the human. 
6 
Consequently, in this study the .unerupted third 
molar of the normal rat was utilized for assessing the 
effects of thyroid hormones on the eruption rate. 
7 
?-1ETHODS AND MA TE RIALS 
• 
Female albino rats were obtained from the Charles 
River Breeding Laboratory, Wilmington, Massachusetts. 
They w~re 26 days of age the day the bioassay procedure 
was begun. Evidence from preliminary experiments indi-
cated that the age of each rat was critical. Because 
of the technique used in preparing treatment drugs, 
(averaging body weights) all rats supplied by Charles 
River were similar in body weights. For example, if 
rats were shipped from Charles River when they were 23 
days of age, only rats with body weights of 53 to 55 
grams would be selected. 
The rats were housed in wire mesh cages (5 rats/ 
cage) over pellicle bedding. The diet consisted of 
Purina laboratory chow and tap water ad libitum. 
On the first day of an experiment (usually a Monday), 
the rats (precisely 26 days of age) were randomly divided 
• 
into 5 groups (control, dose 1,2,3,4). Each rat within 
a group was ear punched for identification during 
weighing and scoring of the extent of tooth eruption. 
The body weights of each rat within a group was obtained. 
All body weights were averaged, to establish a mean 
body weight which was used to prepare the dosages of the 
standard drug. 
The high dose was 18.75 ug/kg body weight. For 
example, a high dose for 50 rats with a mean weight of 
9 
• 
68 · gms. ~ould be 1.275 ug/68 g rat. All doses were 
prepared to be injected in 0.25 ml., subcutaneously. 
A s~ock solution of the standard was prepared 
(1000 ml) to avoid handling and weighing minute quanti-
ties of drug. 
Before the standard drug was added to 1000 ml of 
demineralized water, it was dissolved with 4 drops of 
l.SN NaOH. If only 4 drops of base were used, it was 
unnecessary to add acid to obtain a neutral pH for the 
stock 1000 ml solution. 
From the stock solution, 30 ml were placed into an 
amber glass bottle and labeled dose #1, 18.75 ug. The 
remaining 3 doses, which decreased in a logarithmic 
fashion, were then prepared and labeled dose #2, #3, 
#4. A control dose of demineralized water was similarly 
bottled. 
At a "fixed" time on the first day of the assay 
(usually Mdnday morning) the animals were injected sc., 
with 0.25 ml of its solution. Between injections, the 
0 
solutions were refrigerated. At the "fixed" time on the 
2nd day (usually Tuesday morning), the drugs were allowed 
to warm to room temperature before being injected. 
After the 2nd injection, the solutions were discarded. 
On the 5th day of the assay at the ''fixed'' time 
(usually a Friday morning) all rats were sacrificed by 
10 
ether inhalation and individual body weights recorded. 
To avoid the possibility of error, one group at a 
time was prepared for eruption s~oring. With heavy 
scissors, cuts were made from the corners of the mouth 
to a point behind the ears, freeing the maxilla and 
cranium, with ears attached, from the mandible and body. 
The ears remained attached for identification of the 
individual rats. 
The 10 prepared maxillae were placed into glass 
bottles containing 95% ethanol and labeled dose #1, 
18.75, dose #2 etc. 
After fixation for at least 12 hours (usually the 
following Monday) the maxillae were scored for the 
extent of eruption. 
The 95% ethanol served not only to preserve the 
maxillae, but also to leach water from the originally 
• pink palatal tissues. This resulted in extremely firm 
and white palatal tissues. Before fixation, the rat 
molars are not easily distinguished from the pink 
palatal tissues. ETOH fixation enhances the pink color 
of the tooth resulting in a contrasting "red'' molar on 
a white tissue background. This contrast greatly 
enhances the accuracy of the visual scoring method. 
Every effort was made to insure that the scoring 
procedure was as free of bias as possible. Thus, labels 
11 
from each of the group containers were covered and 
labeled A,B,C,D,E. One group at a time was re moved, 
scored, and returned before the next group was scored. 
All ten maxillae were removed, blotted dry and examined 
under a disecting microscope (A.O. Spencer - l00X). 
The stage of eruption of a third molar was determined 
by comparing it to the standardized scoring chart (see 
fig. #1). The scoring chart depicts eleven progressive 
stages in the eruption of the maxillary right and left 
3rd molars. This chart also contains a number, or grade, 
for each of the eleven pictures (from O for no eruption, 
to 10 for complete eruption). 
The 3rd molar (right or left) that exhibited the 
most advanced stage of eruption was scored. For example, 
in a case where the right third molar was fully erupted 
and the left third molar was only half erupted, the fully 
;. 
erupted right molar was selected for grading. The 
examiner then compared the molar to the scoring chart 
choosing the picture that best resembled the amount of 
molar eruption seen in the microscope. In doing this, the 
examiner also selected the score for that picture. This 
score was recorded on a scoring sheet under the individual 
ear punch of each rat within the group. When scoring for 
a group was completed, that collection of scores on the 
scoring sheet was marked or titled "A", B, c, D, or E, 
12 
referring to the covered container marked the same. The 
scored "A" group was retuined to its container and the 
procedure repeated for the remaining groups i.e. B, C, · 
D, E. 
After scoring, the container cover . marked ''A" was 
removed, revealing the original label. For example, under 
cover "A" might be dose #2 .9375 ug. All scores for that 
group were transferred to the original body weight chart 
and recorded there under the proper ear mark identification. 
Cover "B'' was then removed and the procedure repe~ted. 
At the completion of the assay procedure, the 
eruption score as well as body weights before and after 
treatment, had been obtained for each individual rat 
within each group ( 1 control, and 4 dose groups). 
Statistical Methods: 
Three and four point assays were designed ~nd 
analyzed using methods described by Bliss (18) and Finney 
(19). Each assay was subjected to an analysis of 
variance. The significant change in response to in-
creasing doses over a linear portion of the dose response 
curve or (slope ''b") was established for each assay. 
The Index of Precission (A= t) was determined for 
comparison between assays and for selection of recommended 
dose levels. Calculations were based on both plain and ·-
log dose vs. linear response. 
13 
RESULTS ' 
In order to fully appreciate the technique presently 
in use, it is necessary to · become familiar with the 
experimentation which preceeded the design of the present 
assay system. 
In the initial experiment, five litters of rats were 
randomly assorted into four groups. The rats were first 
observed at 25 days of age and on succeeding days for 
clinical signs of eruption of the maxillary 3rd molars. 
Clinical eruption was determined by anesthetizing each 
rat and, with the aid of an E.N.T. mirror, observing the 
areas distal to the maxillary 2nd molars. A 3rd molar 
was classified as erupted when any part of the crown 
could be seen projecting through the gingiva. All rats 
were weighed and injected each day of the experiment. 
The control group received 0.25 ml demineralized H20; 
group II, 0.25 ml of 75 ug/kg rat of T3 ; group.III, 150 
ug/kg rat of T3 and group IV, 300 ug/kg rat. The results 
indicated that rats from 25 through 28 days of age showed 
no clinical eruption of maxillary 3rd molars. At 29 
days of age, the results were as follows: 1 out of 8 
controls had erupted third molars; 1 out of 12 in group 
II; 2 out of 11 in group III; and 3 out of 8 in group IV 
or the 300ug/kg rat group. At 30 days, 4 out of 8 in 
group III and 7 out of 8 in group IV showed eruption. 
By 31 days all controls demonstrated erupted maxillary 
15 
3rd molars. On day 31 (the day that all rats were 31 
days of age) the mean body _weights for each group were 
as foll~~s: Controls, 93 grams; ~roup II, 95 grams; 
group III, 93 grams; and group IV, 89 grams. 
This initial experiment answered several basic 
questions essential to proceeding further in developing 
the rat molar bioassay. For example, these results 
indicated that one could use small animals (rats) that 
had unerupted maxillary 3rd molars and that thyroid · 
hormones could accelerate the rate of eruption of these 
teeth. It was also evident that increasing the dose of 
thyroid hormone caused an increased rate of maxillary 
3rd molar eruption. Furthermore, the mean body weights 
taken at the end of the experiment, appeared to reflect 
drug side effects. For example, the control group was 
93 gra~s as compared to a weight of 89 grams for group 
IV. 
The value of utilizing rats younger than 25 days of 
age was then investigated. The first experiment described 
above was repeated except that 19 instead of 25 day old 
rats were used. The results of experiment #2 indicated 
that no maxillary 3rd molars erupted in any rats until 
the 27th day. On the 27th day (all rats 27 days old) 
neither controls nor the 75 ug group showed 3rd molar 
eruption; however, the 150 ug group (group III) had 
16 
1 ou t of 10 eru p tions, and the 300 ug group (grou IV) 
had 2 out of 9 eruptions. On the 28 th day, controls 
failed t o show eruption of 3rd molars; grou II h d 6 
out of 10, group IV, 8 out of 9. By the 29th day 11 
treat ment group s sh owed 3rd molar ru tion. Ho v r, 
controls again fa ile d t o demonstrate ruption. On the 
30th day 1 out of 1 0 control rats sh owed maxillary 3rd 
molar eruption. By day 31, 7 out of 1 0 rats pre ented 
clinical eruption of 3rd mo la r s. 
on day 31. 
11 rats were sa cr ificed 
The results of exper iment 2 enabled certain general-
izations to be made. The time and ffort ~nvolved in 
using rats at 19 days of age vs. 25 da y s of ge offered 
little practical advantage in term s of assessing t he 
effect of hormones on 3rd molar eruption. he esults 
again showed that increas i ng th e d os age of 3 aused n 
• increased number of 3rd molars t o e rupt. It al so b ecame 
apparent that a more sophistica te d ap pro ach o r eter-
mining 3rd molar eruption oul d b e of ons iderable alue. 
This was concluded after observ in g several rats nder 
disecting microscope. What was linical ly h o ught o 
be 11 no eruption '' was in some cases ct ually inute 
clinical eruption (o ne usp slightly hrough the is sue ). 
And, conversely, m lars tha visu a lly ppeare o e 
erupte might b o v e r ed with thi yer f tis sue. 
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Consequently, a scoring system was designed with 
which the extent a 3rd molar had erupted through the 
tissue could be established. Atter careful study of 
approximately 100 preserved rat heads, from experiments 
11 and #2, sketches were made of the right and left 
maxillary 3rd molar areas in which the amount of tooth 
structure projecting through the tissue was depicted. 
These sketches were sorted and placed into groups. Each 
group contained the sketches of those teeth ·that had a 
like amount of tooth structure erupting through the 
tissue. Eleven different groups, ranging from sketches 
showing no eruption to those showing a full erupted 
maxillary 3rd molar were compiled and a grade given to 
each group ( O through 10 ). Zero represented no 
eruption and 10 represented full eruption. 
A pictorial scoring chart (figure 1) was constructed. 
~ 
Eleven different drawings were made of the upper dental 
arch showing the right and left third molars distal to 
the 2nd molars. The drawings show the amount a 3rd 
molar (right and left) has erupted through the tissue 
at each of the particular stages of eruption ( 0 - 10). 
The corresponding number grade is also shown in each of 
the pictures. 
After the grading system had been constructed, an 
experiment was designed to answer the following questions: 
18 
1. could the system be utilized? ; 2. could th 
entire assay be run in a shorter period of time, five 
days fLr example? and, finally, were daily injections 
of T3 necessary or would fewer injections be sufficient 
to significantly accelerate molar eruption over that 
of controls? 
Experiment #3 utilized fifty rats, male and fema le, 
all 25 days old. The rats were randomly assorted into 
5 groups of 10 rats per group. The control group wa s 
injected subcutaneously with 0.25 ml. demineralized H2o 
each day of the experiment. Group II received on ly one 
0.25 ml. injection of T3 at 300 ug/kg on t he 25th day. 
Group III received 0.25 ml of T 3 at 3 00 ug/kg on the 
25th and 26th day. Group IV received the sa me dose of 
T3 but on the 25th, 26th, and 27th day. Group V received 
injections on the 25th, 26th, 27th, a nd 28th day. Body 
~ 
weights were recorded on the 25th day a nd the day of 
sacrifice (the 29th day). The results, shown in table 
1, indicated that a significant acceleration in the 
eruption of the maxillary 3rd molars could be achieved 
in a 5 day experiment and, that a possible indication 
of side effect of the thyroid hormone could be estab -
lished by measuring chang~s in body weight. The data 
also indicated that an injection on each da y of the 
experiment was not nee s ary. Injecting on only th 25th 
19 
and 26th days, resulted in the highest eruption score 
with the lowest standard deviation. Finally, the newly 
designed grading system proved ~o be practical and easy 
to use. 
The results of experiment #3 permitted the adoption of 
certain guidelines to be used in subsequent assay 
procedures. Rats were to be weighed the first and last 
day of the assay (on the 25th and 29th days of age). All 
groups would receive injections on only the first and 
second day. Rat molar eruption would be scored as to 
amount of eruption rather than being noted as clinically 
erupted or not erupted. 
An effort was made to establish a more closely 
controlled system. Rats (all female) were supplied by 
Charles River with closely controlled body weights. For 
example the weights of 23 day old female rats shipped 
by Charles River would be either 53, 54, or 55 grams (a 
3 gram range). 
The next experiment (experiment #4), was designed tt> 
utilize the above guidelines and improvements. Fifty-
four albino rats (all female) were divided ~nto 4 groups 
(one con~rol and three T3 treatment groups) and received 
0.25 ml of T3 subcutaneously on the first and second ·day 
of the assay. The treatment dosage was as follows: Group 
II, 75 ug/kg; Group III, 150 ug/kg; Group IV, 300 ug/kg. 
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In experiment #4 the rats were 26 rather than 25 days 
of age, and thus they were started and sacrificed one 
day later than in experiment #3. 
The data from experiment #4 (table 2) indicated 
that increasing the age of the rats from 25 to 26 days, 
resulted in a significant ( p < . 05) increase in eruption 
scores. 
The slope of the dose response curve was significant 
(p (.OS) and linear. It was also found that, by plotting 
only 2 log doses rather than 3 log doses (dropping the 
300 ug/kg dose), that the slope increased from 5.8 to 
8.3 ( a 43% improvement while the index of precision 
improved from .494 to .345. 
Body weights were statistically evaluated, first, 
as a net weight gain (starting weights minus final weights) 
and secondly, by evaluating the mean group weights at 
initial and final weighing. The results (table 2) indi-
cate that only the group receiving 300 ug showed a 
significant ( p <. • 05) net weight loss. This is not to 
say that the 300 ug group did not gain weight but that 
they gained less weight than the control groups. Likewise, 
in the mean group weights only t~e 300 ug treatment group 
showed a significantly ( p L... •01) lower mean weight at the 
final weighing compared to controls. 
The results of experiment #4 enabled a critical 
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evaluation of the status of the rat molar bioassay system 
to be made. 
The system appeared to satisfy the structural require-
ments of a biological assay in relation to stimulus, 
subject, and response. (19) By using 25 day old instead 
of 26 day old rats, all scores increased yet treatment 
groups (except for the 75 ug group) remained significantly 
higher ( p< .05) than controls. 
The bioassay procedure was considered to be rapid 
• 
(run in 5 days), convenient (injected and weighed only 
twice), inexpensive, and statistically valid. The scoring 
system appeared to be consistant and uncomplicated. 
Assessing possible drug side effect by measuring body 
weight alterations appeared to be an adequate means of 
quickly evaluating the degree of general toxicity of a 
drug. For the above reasons, the rat molar biqassay was 
adopted as a valid system, utilizing T3 as the standard 
preparation. 
The next logical step was to proceed with the assay 
of a test drug. According to Finney (19) any test prepa-
ration of the stimulus, having an unknown potency, is 
assayed by finding the mean response to a selected dose, 
and equating this dose to that of the standard preparation 
shown by experiment to produce the same mean response. 
Experimentation with several different doses of one or both 
22 
preparations is almost always needed in order to accom-
plish this satisfactorily. · 
Several studies have shown that IsoI 2 is, at present 
the most potent of the thyroxine analogs and derivatives 
available (20, 12, 14, 15). For this reason, IsoI2 was 
chosen as a test preparation, and in experiment #5, the 
rat molar bioassay was set up to test IsoI2, using 26 
day old female albino rats. Four doses were administered: 
150 ug/kg, 75 ug/kg, 38 ug/kg, and 19 ug/kg. Controls 
received demineralized water. 
The results (table #3) indicated that all animals 
had a net weight gain. However, in comparing net weight 
gains of treatment group vs. controls, dose groups 19 ug 
and 38 ug showed a significant (p ~ • 001) and (p < • 01) 
increase in weight. Conversely, in comparing the mean 
group weights (initial and final) there was no ~ignificant 
difference (p> .OS) between groups and controls. The data 
in table 3 points out clearly that all treatment groups had 
a significant acceleration in 3rd molar eruption. Further-
more, the dose response curve (figure 2) indicated that 
the ability of IsoI 2 to accelerate 3rd molar eruption 
had peaked; that is, the response did not increase with 
increasing doses. This information indicated that smaller 
doses of IsoI2 should be tested. In experiment #6 four 
doses of IsoI 2 , ranging from 19 ug/kg · to 2.3 ug/kg were 
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administered. The results of this experiment (table #4) 
showed that all doses of IsoI2, with the exception of 2.3 
ug/kg, caused a significant inciease in 3rd molar eruptiun. 
A very important result was that the 4 doses used, estab-
lished a slope that was both statistically significant 
and linear. Furthermore, by deleting the 19 dose both 
the slope and index of precision were improved. The 
drug had no significant effects on weight gain. 
A replication of experiment #6 (experiment #7) produced 
the following results (Table 5). Except for the low dose 
of 2.3 ug, all treatment groups showed a significant (p(.05) 
increase in molar eruption. It was also observed that 
toxicity, as indicated by weight alterations was not sig-
nificant. As with experiment #6, all slopes (plain and 
log dose) were significant and linear: however, by using 
only 3 log doses in plotting the dose response curve, 
there was an improvement in the slope (4.25 vs 5.81) and 
in the index of precision (.565 vs •• 413). 
Analysis of variance indicated that experiment #6 and 
7 could be combined giving the results seen in table 6. 
All treatment groups, except for those receiving the low 
dose showed significantly higher eruption scores (p(.05) 
than controls. A significant difference (p< 05) between 
certain doses also existed (2.3-4.7, 2.3-9.4, 2.3-19, 4.7 
-19). Again all slopes were statistically significant and 
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linear. By using 3 log doses (dropping 19 ugl the slope 
was 6.31 while the index of precision was .388. 
After comparing the dose response curves (figure i3l 
of T3 and tsoI 2 as well as the weight changes produced 
by these thyroid homones, it was decided to delete T3 
and adopt 1soI2 as the standard preparation for use in 
the rat molar bioassay procedure. 
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DISCUSSION 
Several questions come to mind when one asks, 
what constitutes a good bioassay system? Certainly, 
economics must be considered. A testing procedure that 
requires expensive, highly sophisticated instrumentation 
has built-in limitations. Sophisticated instruments 
usually require the use of specialized, well trained 
personnel. Will the procedure be simple or will it be 
extremely complicated? Does the testing procedure require 
hours, days, weeks? Will the responses (end points) be 
readily determined and reproducible or will the system be 
so sensitive that changes in humidity, as an example, 
modify the response. Finally, how important is the bioassay 
procedure? Is it a preliminary screen that will only 
indicate drugs that exhibit specific potentials; or, is it 
a rigorous system that will determine the ultimate clinical 
utility of drugs. ~ 
An assay procedure that ·is expensive, complicated, and 
long lasting, that is to be used only to establish general 
responses and side effects in small lower animals, has a 
number of obvious disadvantages. 
The overall goal of this study was to find a drug 
that wo~ld produce acceleration of tooth eruption in hum~ns 
with little (or no) toxicity. Accordingly, we attempted to 
design and describe a testing system that would quickly 
indicate drugs with the potential to speed the eruption 
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of teeth. 
Since our principle intent was to develop only a 
screening procedure, we particularly wanted the bioassay 
to be easy and quick to operate, inexpensive, accurate, 
highly reproducible, and which would provide substantial 
evidence concerning a drug's potential to accelerate 
tooth eruption and its general toxicity. What was achieved? 
Utilizing rat molars as a parameter for indicating acceler-
ation in tooth eruption, marks a shift from conventional 
studies on the eruption of teeth (3,4,5,6,7). Rat molars, 
as indicated, provide a testing medium that is more closely 
correlated with the human dentition. For this reason, it 
may be a more effective parameter. 
It is important to note that all animals used in 
these experiments were euthyroid. By rendering the test 
animals hypothyroid, it might be possible to markedly 
increase the sensitivity of the eruptive mechanism to the 
test drugs . (7). The decision to utilize normal animals 
was based on the fact that the ultimate use of these agents 
would be in normal patients. 
The rat molar bioassay procedure is relatively 
inexpensive. Each run requires the purchase and upkeep o~ 
50 rats for only 5 days. It requires only one employee who 
can follow simple directions. Time and effort are mini-
mal. The assay procedure takes 2 hours the first day; 30 
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minutes the second day; and, an additional 2 hours to 
sacrifice, prepare and score molar eruption. This is a 
total of only 4½ hours. Anyone who can use an analy t ic a l 
balance, inject rats and match pictures can run this ass ay. 
The sensitivity of the rat molar assay procedure can 
best be described by an examination of figure #3. A dose 
of 75 ug/kg body weight of T3 resulted in little 3rd molar 
acceleration. However, by increasing the dosage to 150 ug/ 
kg, 3rd molar eruption was enhanced almost 2 times, and 
by administering a dose of 300 ug/kg, molar eruption was 
advanced over two times. This, in itself, indicates that 
one specific drug can be assayed and a varying response 
can be plotted by varying the dosage. However, this d oes 
not reflect the true sensitivity of the assay . By com-
paring IsoI 2 and T3 it can be seen that rodent 3rd molar 
eruption is extremely sensitive to the effects bf thyro-
mimetic agents. With a dose of only 04.7 ug/kg IsoI2 
accelerated 3rd molar eruption 2½_ times. At a dose of 
09.4 ug/kg the eruption rate was increased 3 times. 
In addition, this dose of IsoI2 caused no side e ffect 
(as determined by body weight alterations). At a dose of 
300 ug/ky, T3 which produced approximately the same eruption 
response, produced body weight changes. 
A measure of the sensitivity of this system i s the 
relative capacity of IsoI2 and T3 to sti mulate tooth 
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eruption. Less than 10 ug/kg (09.4 ug/kg) of IsoI2 will 
elicit the same response as 300 ug/kg of T3• This repre-
sents a 32 fold increase in dosage. 
Rats varying 24 hours in age may show significant 
differences in regard to 3rd molar eruption scores. The 
consistency of control scores in experiment #4, 5,6, and 
7 point out that the commercial suppliers were more precise 
than might have been expected. It is possible, however, 
that the precision of the assay could be enhanced even 
further if the age of the animals were more closely 
controlled. 
The index of precision of the rat molar bioassay is 
now approximatelyA = 0.35. An extensive study by Stasilli 
and Kroc (21) indicates that the antigoitrogenic assay has 
~ values of approximately 0.15. This is approximately 4 
times more precise than the rat molar assay. However, a 
• 
close examination of their results indicates that their low 
index of precision value ( A ) is derived from a high slope 
value (b) and not a low (s) value. Their slope values are 
in the area of 40 while theirs values are 4 to 5, or two 
times greater than ours values. In short, Kroc and 
Stasilli reported a good index of precision because of a 
steep dose response slope not because of goods values. 
It should also be considered that the antigoitrogenic 
assay animals are not normal animals. They are, in fact, 
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"hypothyroid" animals. Consequently, the response to 
thyromimetic agents should be greatly exaggerated. Finally, 
the Kroc antigoitrogenic assay lasted 14 days not 5 days, 
as with the rat molar assay. 
31 
SU?-iMARY AND CONCLUSION 
A bioassay procedure that rapidly screens drugs to 
determine their ability to ·accelerate tooth eruption as 
well as their general side effects was designed. 
The .method for assessing changes in the rate of 
tooth eruption utilized the maxillary third molar of the 
26 day old female albino rat. 
The assay system has been shown to be statistically 
valid, rapid, easy to utilize, and inexpensive, while 
exhibiting acceptable sensitivity and reproducibility. 
However, its potential has yet to be fully explored. 
Improved methods for scoring 3rd molar eruption and 
assessing drug toxicity need to be investigated. Possible 
methods to improve the precision of the assay system also 
need to be ,studied. 
Nevertheless, it is felt that the marked sensitivity 
of 3rd molar eruption to thyromimetic agents, suggests that 
• 
this technique may be useful in the search for clinically 
useful compounds. 
In addition to its use as a means of rapidly screening 
drugs for their affects on tooth eruption, it is possible 
that this technique could be of use for the bioassay of 
thyroid hormone preparations. The present standard U.S.P ~ 
bioassay for thyroid hormones is the rat antigoitrogenic 
assay. In comparison to the antigoitrogenic assay the 
tooth eruption assay is simpler, more rapid, it's 
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reproducibility is higher, it requires much less test 
material, and our experience to date suggests that it 
has an index of precision approaching that of the anti-
goitrogenic assay. Should further work substantiate 
these apparent advantages of the tooth eruption assay, 
it is conceivable that it would at lease join, the anti-
goitrogenic assay as the standard means of assessing the 
potency of thyroid hormone preparations. 
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APPENDIX 
TABLE 1. Experiment #3. Effects of varying the number* 
of injections of T3 at 300 ug/kg on maxillary 
3rd molar e·ruption rate. 
Treatment 
Control (10) 
T3 300 ug/kg 1 injection* (10) 
T3 300 ug/kg 2 injection* (10) 
T3 300 ug/kg 3 injection* (10) 
T3 300 ug/kg 4 injection* (10) 
Eruption 
Score+ 
o.s ± .67 
1.4 ± 1.7 
3.7 ± 1.7 
3.4 ± 2.8 
3.7 ± 1.9 
Gain in 
body wt. 
gm. 
+ 20.7 
+ 20.7 
+14.l 
+ 8.3 
+ 5.8 
+means± s.d. Number of rats in parenthesis. All 
rats 25 days of age at start of treatment. Eruption 
scored at 29 days of age. Body weight evaluations are 
means of final weights less beginning weights (+ equal 
net gain, - equal net loss). All injection sc (0.25 
ml injection). 
*l injection 
-
injection on the 25th day l, 
2 injection - injection on the 25th and 26th day 
3 injection - injection on the 25th, 26th, and 
-
27th day 
4 injection - injection on the 25th, 26th, and 
-
27th and 28th day 
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TABLE 2. Experiment #4. Effects of T3 on the eruption 
rate of maxillary 3rd molars and body weights 
of 30 day old female rats. 
Eruption Rate 
Treatment 
Control (12) 
75 ug/kg (14) 
150 ug/kg (14) 
300 ug/kg (14) 
Body Weight Changes 
Treatment 
Control 
75 ug/kg 
150 ug/kg 
300 ug/kg 
(12) 
(14) 
(14) 
(14) 
Eruption 
Score 
2.9 
3.3 
5.8 
6.8 
± 
± 
± 
± 
0.8 
0.8 
0.8* 
0.8** 
Net Weight 
Gains 
+18 ± 1.2 
+17 ± 1.1 
+18 ± 1.1 
+14 ± 1.1* 
3 Log 
Doses 
J = .494 ] -"= 5.8 
2 Log 
Doses 
Mean Group Weight 
(not gain) 
Initial Final 
63 ± 1.8 
60 ± 1.7 
62 ± 1.7 
60 ± 1.7 
.. 
81 
77 
80 
74 
± 
± 
± 
± 
1.8 
1.7 
1.7 
1.7** 
Values are means± SE. Number of rats in parenthesis. 
All rats 26 days of age at start of treatment. Eruption 
scored at 30 days of age. T 3 (75 ug/kg, 150 ug/kg, 300 ug/ 
kg) injected scat 26 and 27 days of age. Body weight 
evaluations are mean net weight changes+ or - and mean 
group weights (not gain) of initial and final body weights. 
Index of precision {A) calculated for 2 and 3 log doses 
slope = l , ~ = index of precision. 
* p <.. .05 
**p < • 01 
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TABLE 3. Experiment i5. Effects of IsoI 2 
rate of maxillary 3rd molars and 
30 day old female albiro rats. 
on the eruption 
body weight of 
Eruption Rate 
Treatment 
Control (11) 
19 ug/kg (11) 
38 ug/kg (11) 
75 ug/kg (10) 
150 ug/kg (10) 
Body Weight Changes 
Treatment 
Control (11) 
19 ug/kg (11) 
38 ug/kg (11) 
75 ug/kg ( 10) 
150 ug/kg (10) 
Net Weight 
Gains 
+16 ± 1.5 
+22 ± 1.5** 
+22 ± 1.5** 
+19 ± 1.6 
+19 ± 1.6 
Eruption Score 
2.2 ± 0.93 
7.5 ± 0.93*** 
6.7 ± 0.98** 
5.4 ± 0.98* 
6.6 ± 0.98** 
4ean Group Weight 
(not gain) 
Initial Final 
69 ± 3.9 85 ± 3.9 
73 ± 3. 9 95 ± 3.9 
73 ± 4.1 95 ± 3.9 
73 ± 4.1 92 ± 4.1 
76 ± 4.1 95 ± 4.1 
Values are means± SE. umber of rats in parenthesis. 
All rats 26 days of age at start of treat ent. Eruption 
scored at 30 days of age. IsoI 2 (19, 38, 75, 150 ug/kg) 
injected scat 26 and 27 days of age. Body weight 
evaluations are: mean net weight changes+ or - and me a n 
group weights (not gain) of initial and final body weights. 
*p < • 05 
**P<-01 
***P< .001 
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TABLE 4. Experiment #6. Effects of IsoI 2 
rate of maxillary 3rd molars ana 
30 day old female rats. 
on the eruption 
body weight of 
Eruption Rate 
Treatment 
Controls (10) 
23 ug/kg ( 10) 
4.7 ug/kg (10) 
9.4 ug/kg (10) 
19 ug/kg (10) 
Eruption 
Score 
2.0 ± 0.75 
2.7 ± 0.79 
4.3 ± 0.79* 
6.8 ± 0.79** 
6.9 ± 0. 7 9** 
Plain Dose Log Dose 
4 3 4 3 
doses doses doses doses 
"'=2.40 -6::5.71 '=5.02 .h=6.81 
).=l.04 A=. 4 38 A=.498 A==.367 
Body Weight Changes 
Treatment Net Weight 
Gains 
Mean Group Weights 
(not gain) 
Initial Final 
Control (10) +24 ± 0.8 68 ± 1.4 
• 
92 ± 1.4 
2.3 ug/kg (10) +21 ± 0.8 70 ± 1.5 91 ± 1.5 
4.7 ug/kg (10) +23 ± 0.8 67 ± 1.5 90 ± 1.5 
9.4 ug/kg (10) +22 ± 0.8 69 ± 1.5 91 ± 1.5 
19 ug/kg (10) +24 ± 0.8 69 ± 1.5 93 ± 1.5 
Values are means± SE. Number of rats in parenthesis. 
All rats 26 dayt of age at start of treatment. Eruption 
rate scored at 30 days of age. IsoI2 (2.3, 4.7, 9.4, 19 ug/ 
kg) injected scat 26 and 27 days of age. Body evaluations 
are mean weight changes+ or-, and means group weights (not 
gain) of initial and final body weights. Index of precis;on 
(A) calculated for 3 and 4 doses for both plain and log 
dose. Slope = ,h ; A = inde!K of precision. 
*p = < • 05 
**p = < • 01 
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TABLES. Experiment #7. (Replication of Experiment #6) 
Effects of IsoI 2 on the eruption rate of 
maxillary 3rd molars and body weight of 30 day 
old female albino rats. 
Eruption Rate 
Treatment 
ug/kg 
Eruption 
Score 
Plain Dose 
4 3 
Log Dose 
4 3 
Control (10) 
2.3 - (10) 
4. 7 (10) 
9.4 (10) 
19 (10) 
2.2 
2.2 
4.9 
5.7 
6.2 
Body Weight Changes 
Treatment 
Control (10) 
2. 3 ug/kg . (10) 
4.7 ug/kg (10) 
9.4 ug/kg (10) 
19 ug/kg (10) 
doses doses doses doses 
± 0.76 
:t 0.76 
"=l.96 ]k=4.48 ± 0.76* k=4.25 ].k=S.81 
± 0.76** ..\=1.22 J=.536 A =.565 .\=.413 
± 0.76** 
Net Weight 
Gains 
+24 ± 0.76 
+23 ± 0.76 
+24 ± 0.76 
+24 ± 0.76 
+24 ± 0.76 
Mean Group Weights 
(not gain) 
Initial Final 
~ 66 ± 1.4 90 ± 1.4 
67 ± 1.4 90 ± 1.4 
65 ± 1.4 89 ± 1.4 
65 ± 1.4 89 ± 1.4 
65 ± 1.4 89 ± 1.4 
Vaules are means± SE. Number of rats in parenthesis. 
All rats 26 days of age at start of treatment. Eruption 
rate scored at 30 days of age. IsoI2 (2.3, . 4.7, 9.4, 19 ug/ 
kg) injected scat 26 and 27 days of age. Body evaluations 
are mean weight changes+ or-, a~d mean group weights 
(not gain) of initial and final body weights. Index of 
precision (A) calculated for 3 and 4 doses for both plain 
and log dose. Slope =Jr : ).. = index of precision. 
*p = <. .OS 
**p =< .01 
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TABLE 6 Effect on eruption scores by combining results 
of Experiment #6 and # 7 (IsoI2 a dose of 2.3, 4.7, 
9 . 4 , 19 u g /kg ) . 
Eruption Rate 
Treatment 
ug/kg 
Controls 
2.3 
4.7 
9.4 
19 
Eruption Scores 
Experiment #6 Experiment #7 
(11) 
( 10) 
( 10) 
(10) 
(10) 
2.0 
2.7 
4.3 
6.8 
6.9 
± 0.74 (10) 
± 0.77 (10) 
± 0.77 ( 10) 
± 0.77 (10) 
± 0.77 (10) 
2.2 ± 0.77 
2.2 ± 0.77 
4.9 + 0.77 
5.7 ± 0.77 
6.2 ± 0.77 
Eruption Rate (Combine Experiment A6 and Experiment #7) 
Treatment 
ug/kg 
Control ( 21) 
2.3 (2 0) 
4.7 (20) 
9.4 (20) 
19 (20) 
Eruption Score 
Both (Exp. #6 & #7) 
2.1 ± 0.53 
2.4 ± 0.55 
4.6 ± 0.55* 
6.2 ± 0.55** 
6.6 ± 0.55** 
4 3 
Log Dose Log Dose 
k= 4.635 ]k= 6 . 312 A = .529 A= .388 
Values are means± SE. Number of rats in parenthesis. 
All rats 26 days of age at st art of treatment. Eruption 
rate scored at 30 days of age. IsoI2 (2 .3, 4.7, 9. , 1.9 
ug/kg) injected scat 26 and 27 days of age. Index of 
precision (A) calculated f or 3 and 4 log doses. Slope 
=k ; ~ = index of precision. 
*p ~. 05 
**p < • 01 
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FIGURE 1. The rat molar bioassay standardized scoring 
chart. The drawings represent the amount 
an upper 3rd molar (right and left) has 
erupted through the tissue at each of eleven 
stages of eruption ( O through 10). 
To determine the eruption score of a par-
ticular treatment rat, compare the treatment 
rat's upper 3rd molar (right or left) that 
exhibits the most advanced stage of eruption 
to the standardized grading chart, selecting 
the picture that resembles the same amount 
• 
of eruption. The score for each stage of 
eruption is located on each picture. 
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STANDARDIZED SCORING CHART 
· FOR 
RAT !-lA.XILLARY 3R.D MOLA..~S 
- - - ----- -
46 
. 
. 
.. 
1--- .. 
- .. --... 
FIGURE 2. Experiment #5. Effects of sc injections 
(at 26 and 27 days of age) of IsoI 2 on the 
eruption rate of maxillary 3rd molars. The 
dose response curve (dose at 19 ug/kg, 38 
ug/kg, 75 ug/kg, and 150 ug/kg) indicated 
that the action of IsoI 2 in accelerating 
3rd molar eruption had peaked, the response 
did not increase with increased dose. This 
implied a need for more dilute portions of 
IsoI2. Eruption was scored at 30 days of 
• 
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FIGURE 3. Dose response curves for L-3' Isopropyl 
3-5 diiodothyronine and L-triiodothryronine. 
Curves show the effects of the drugs on the 
eruption rate of the maxillary 3rd molars 
of the rat. Values shown are means± S.E. 
The T3 curve (right) is based on results 
from Experiment #4, Table 2. The isopropyl 
curve (left) is based on data from Experi-
ment #6 and #7 (combined) Table 6. In both 
experiments drugs were injected sc to albino 
rats at 26 days of age and again at 27 days. 
Third molar eruption was scored at 30 days. 
Both slopes are significant and linear. 
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